Novartis to make COVID-19 vaccine developed by Massachusetts scientists

CNBC reports that Novartis (NVS +2.5%) has agreed to manufacture an adeno-associated virus (AAV) COVID-19 vaccine developed by scientists at Harvard, Mass Eye & Ear and Massachusetts General Hospital.

The company’s AveXis unit will make the vaccine “at no cost.”

Clinical trials are expected to launch in H2.

https://seekingalpha.com/news/3578318-novartis-to-make-covidminus-19-vaccine-developed-massachusetts-scientists